Antibody-guided nanoparticles target blood cancer cells in bone marrow‎

New research co-led by Indiana University School of Medicine scientists presents a significant step toward more precise and effective cancer treatments by using a breakthrough method to deliver therapies directly to cancer cells. The study was recently published in ACS Nano.